Binnewies et al. identified cDC2s that present tumor-derived antigens to CD4+ T cells but fail to support the anti-tumor differentiation of CD4+ T cells in tumor draining lymph nodes of mice [62]. The gene discussed is CD4; the disease is neoplasm.